generated: '2026-08-26'
method: searched
source: https://nusano.com/ (site walk, 2026-08-26) + https://nusano.com/wp-json/wp/v2
versioning:
  scheme: WordPress REST namespace versioning (wp/v2) — inherited from the CMS, not authored by Nusano.
  current: wp/v2
  policy_published: false
  policy_url: null
deprecation:
  policy_published: false
  policy_url: null
  sunset_header: false
  deprecation_header: false
  deprecated_operations: []
  note: No deprecation or sunset policy, and no RFC 8594 Sunset/Deprecation headers were observed. No
    Deprecation pointer is emitted in apis.yml.
status_page:
  published: false
  url: null
  probed:
  - url: https://status.nusano.com
    result: NXDOMAIN
  note: No status page on any host. status.nusano.com does not resolve. No StatusPage pointer is emitted.
sla:
  published: false
  url: null
  note: Nusano is a radioisotope manufacturer; its published commitments are isotope supply agreements
    (Ratio Therapeutics, Ariceum Therapeutics, Clarity Pharmaceuticals), not API service levels.
changelog:
  published: false
  url: null
  note: No dated API changelog. The company newsroom at https://nusano.com/news/ is a press-release feed,
    not a release-note stream, so no ChangeLog pointer is emitted.
company_milestones:
- date: '2026-06-25'
  event: '"Beam on Target" — particles accelerated through the LEBT and RFQ sections of the LINAC to a
    target at 28% of full energy; first of three milestones to bring the production platform online by
    end of 2026.'
  source: https://nusano.com/beam-on-target-milestone/
- date: '2025-08-21'
  event: Ribbon cutting on the 190,000-square-foot radioisotope production facility in West Valley City,
    Utah.
  source: https://nusano.com/nusano-cuts-ribbon-on-state-of-the-art-radioisotope-production-facility/
- date: 2024-10
  event: Series C financing of over $115M announced to commercialize radioisotopes.
  source: https://nusano.com/series-c/